Cell line: HeLa Cells
Cell type: Human cervix carcinoma
Origin: Taken from cervix carcinoma of a 31 year Henrietta Lacks in 1951
Morphology: Epithelial-like cells growing in monolayers

Showing posts with label Rebecca Skloot. Show all posts
Showing posts with label Rebecca Skloot. Show all posts

Rebecca Skloot writing style


Rebecca Skloot is an American science writer and author who is known for her ability to convey complex scientific concepts in a way that is both engaging and accessible to a wide audience. Her writing style is characterized by her use of descriptive language, personal anecdotes, and storytelling elements, as well as her reliance on research and interviews to provide context and depth to her work.

Henrietta Lacks: A Donor's Immortal Legacy

In 1951, an African-American woman named Henrietta Lacks was diagnosed with terminal cervical cancer. She was treated at Johns Hopkins University, where a doctor named George Gey snipped cells from her cervix without telling her. Gey discovered that Lacks' cells could not only be kept alive, but would also grow indefinitely.

For the past 60 years Lacks' cells have been cultured and used in experiments ranging from determining the long-term effects of radiation to testing the live polio vaccine. Her cells were commercialized and have generated millions of dollars in profit for the medical researchers who patented her tissue.

Lacks' family, however, didn't know the cell cultures existed until more than 20 years after her death. Medical writer Rebecca Skloot examines the legacy of Lacks' contribution to science — and effect that has had on her family — in her new book, The Immortal Life of Henrietta Lacks.

List to Medical writer Rebecca Skloot examining the legacy of Lacks' contribution to science.

HeLa Cells - News